Clophosome®-A – Clodronate Liposomes (Anionic), Suitable for macrophage depletion (F70101C-A)
$268.00 – $949.00
| SKU | Stock | SIZE (ml) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| F70101C-A-2 | Yes | 2 ML | $268.00 | |||
| F70101C-A-10 | Yes | 10 ML | $949.00 |
- Description
- Terms
- Additional information
- Documents
- References
- Reviews (0)
Description
Clophosome®-A- Clodronate Liposomes (Anionic), Suitable for macrophage depletion
Clophosome®-A, negatively-charged clodronate liposomes, offers superior efficiency of macrophage depletion. Clodronate molecules are encapsulated in LUV liposomes for superior activity, physical and chemical stability, and convenience of use. It is formulated to an exceptionally high clodronate/lipid ratio. Free clodronate is cleaned out and the liposomal encapsulation efficiency of clodronate is more than 90%. Clophosome liposomes remain homogenous even after long-term storage in the fridge. It is not viscous and easy to inject even with fine needles. It is manufactured sterile for long term shelf-life.
The product is suitable for dosing with various routes including intravenous, intraperitoneal, subcutaneous, intranasal, intratracheal and etc. We have achieved > 90% depletion in splenic macrophages (red pulp macrophages) 24 hours after a single 0.2 mL intravenous injection. A starting dose of 0.15-2 mL (i.v. or i.p.) for 20-25g animal body weight is recommended for good consistency in macrophage depletion. Optimization is recommended for specific applications.
Specifications
Product name: Clophosome®-A
Product code: F70101C-A
Active: clodronate disodium. CAS: 22560-50-5, 7 mg/mL
Lipid composition: phosphatidylglycerol, phosphatidylcholine, and cholesterol
Bulk solution: phosphate buffered saline (20mM sodium phosphate, 09wt% NaCl), pH 7.0-7.5
Shelf-life: 6 months guaranteed for unopened vials at 2-8 degree C
Research use only.
Additional information
| SIZE (ml) | 10 ML, 2 ML |
|---|
1. Duan, R., Milton, P., Sittplangkoon, C., Liu, X., Sui, Z., Boyce, B. F., & Yao, Z. (2024). Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy. Cancer immunology, immunotherapy : CII, 73(10), 203. https://doi.org/10.1007/s00262-024-03788-1
2. Kurashiki, Y., Kagusa, H., Yagi, K., Kinouchi, T., Sumiyoshi, M., Miyamoto, T., Shimada, K., Kitazato, K. T., Uto, Y., & Takagi, Y. (2022) Role of post-ischemic phase-dependent modulation of anti-inflammatory M2-type macrophages against rat brain damage. Journal of Cerebral Blood Flow & Metabolism. 43(4):531-541. https://doi.org/10.1177/0271678X221147090
3. Kurashiki, Y., Kagusa, H., Yagi, K., Kinouchi, T., Sumiyoshi, M., Miyamoto, T., Shimada, K., Kitazato, K. T., Uto, Y., & Takagi, Y. (2022). Role of M2-type macrophage-specific modulation in a time-dependent manner against post-ischemic brain damage in rat. Research Square. https://doi.org/10.21203/rs.3.rs-1636935/v1
4. Ho, Y., Bregni, G., Stazi, M., Peinado, P., Chen, P., Ballabio, C., Boulat, V., Vadera, S., Guan, Y., Liu, Z., Alonso de la Vega, A., Wang, L., Ho, C., Veiga-Fernandes, H., Downward, J., Hsieh, M., Kopanitsa, M. V., Kassiotis, G., Tsantoulas, C., … & Li, L. (2026). Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer. Cell. https://doi.org/10.1016/j.cell.2026.04.038
Research use only.
Be the first to review “Clophosome®-A – Clodronate Liposomes (Anionic), Suitable for macrophage depletion (F70101C-A)”
You must be logged in to post a review.
Reviews
There are no reviews yet.